Newsfeeds Archive - Page 2 of 3

1 minute read

Movers
News

Why ProMIS Neurosciences Stock Surged Today

July 17, 2:22 PM

ProMIS Neurosciences Inc. (NASDAQ: PMN) shares skyrocketed Monday after the company presented preclinical data supporting the potential therapeutic advantage of its lead candidate for Alzheimer's disease (AD), PMN310, and additional studies that further characterize a computationally-derived AD vaccine <

PMN

4 minute read

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

July 17, 1:14 PM

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.

ABOS

3 minute read

Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Results

By Lisa Levin

July 17, 12:16 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Monday. The Dow traded up 0.19% to 34,574.01 while the NASDAQ rose 0.71% to 14,214.50. The S&P 500, also rose, gaining, 0.31% to 4,519.25.

BBIO

3 minute read

US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In July

By Lisa Levin

July 17, 10:01 AM

U.S. stocks traded slightly higher this morning, with the Dow Jones moving higher by around 20 points on Monday. Following the market opening Monday, the Dow traded up 0.06% to 34,529.57 while the NASDAQ rose 0.25% to 14,149.04. The S&P 500, also rose, gaining, 0.06% to 4,508.18.

ABOS

3 minute read

Reported Earlier, ProMIS Showcases Preclinical Data At The Alzheimer’s Association International Conference 2023 On Computationally-Derived Antibody And Vaccine From Alzheimer’s Pipeline

By Happy Mohamed

July 17, 9:44 AM

New findings highlight that PMN310 was able to target toxic amyloid-beta oligomers more selectively than other amyloid-beta-directed antibodies which were generated using synthetic oligomers Rationally

PMN

4 minute read

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

July 10, 12:34 PM

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the U.S. Department of Defense.

AAN

2 minute read

ProMIS Neurosciences Announces FDA Clearance Of Investigational New Drug Application For PMN310 In Alzheimer’s Disease

By Happy Mohamed

May 8, 9:04 AM

In preclinical studies, PMN310 demonstrated the ability to selectively target and protect against pathogenic Aβ oligomers The IND clearance of PMN310 in

PMN

2 minute read

ProMIS Neurosciences Inc. PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared To Other Amyloid-Beta-Directed Antibodies In Poster Presentation At AD/PD 2023

By Happy Mohamed

March 29, 8:37 AM

ProMIS Neurosciences Inc. (TSX:PMN) (NASDAQ:PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as

PMN

3 minute read

Reported Late Wednesday March 08, ProMIS Neurosciences Announces FY22 Financial Results And Recent Highlights; Cash And Cash Equivalents Were $5.9M As Of December 31, 2022 Vs $16.9M YoY

By Happy Mohamed

March 9, 1:33 AM

Completed all preclinical studies and manufacturing to support PMN310 IND submission to U.S. Food and Drug Administration Preclinical data that further characterize ongoing programs, including PMN310, to be presented

PMN

1 minute read

ProMIS Neurosciences Q3 EPS $(0.85) Down From $(0.20) YoY

By Benzinga Newsdesk

November 14, 8:29 AM

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.85) per share. This is a 325 percent decrease over losses of $(0.20) per share from the same period last year.

PMN